Review
Aug 2026
ZEB1 orchestrates cellular plasticity and therapy resistance in prostate cancer: from molecular mechanisms to clinical targeting.
This review highlights ZEB1 to resistance against standard-of-care treatments by metabolic reprogramming and modulation of androgen receptor signaling, and explores strategies to disrupt the regulatory circuitry of ZEB1 to overcome multidrug resistance.
Qianqian Wang, Jianing Wang, Yuxuan Zhao et al.
· Critical reviews in oncology... · 0 citations